EA200901042A1 - Производные 1-бензенсульфонил-1h-индола в качестве ингибиторов активности ccr9 - Google Patents
Производные 1-бензенсульфонил-1h-индола в качестве ингибиторов активности ccr9Info
- Publication number
- EA200901042A1 EA200901042A1 EA200901042A EA200901042A EA200901042A1 EA 200901042 A1 EA200901042 A1 EA 200901042A1 EA 200901042 A EA200901042 A EA 200901042A EA 200901042 A EA200901042 A EA 200901042A EA 200901042 A1 EA200901042 A1 EA 200901042A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- ccr9
- benzulfonil
- indol
- derivatives
- activity inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Transplantation (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
В настоящем изобретении предлагаются 1-бензенсульфонил-1Н-индолы, способы их получения и применения в качестве фармацевтических препаратов, например, для лечения нарушений, опосредованных CCR9, таких как, например, воспалительное заболевание кишечника.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07101784 | 2007-02-06 | ||
PCT/EP2008/051365 WO2008095908A1 (en) | 2007-02-06 | 2008-02-04 | 1-benzenesulfonyl-1h-indole derivatives as inhibitors of ccr9 activity |
Publications (1)
Publication Number | Publication Date |
---|---|
EA200901042A1 true EA200901042A1 (ru) | 2010-02-26 |
Family
ID=38226351
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200901042A EA200901042A1 (ru) | 2007-02-06 | 2008-02-04 | Производные 1-бензенсульфонил-1h-индола в качестве ингибиторов активности ccr9 |
Country Status (13)
Country | Link |
---|---|
US (1) | US20100075963A1 (ru) |
EP (1) | EP2118060B1 (ru) |
JP (1) | JP2010517976A (ru) |
KR (1) | KR20090116732A (ru) |
CN (1) | CN101605759A (ru) |
AT (1) | ATE483685T1 (ru) |
AU (1) | AU2008212887A1 (ru) |
BR (1) | BRPI0807836A2 (ru) |
CA (1) | CA2676145A1 (ru) |
DE (1) | DE602008002901D1 (ru) |
EA (1) | EA200901042A1 (ru) |
MX (1) | MX2009008425A (ru) |
WO (1) | WO2008095908A1 (ru) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI429628B (zh) | 2010-03-29 | 2014-03-11 | Univ Taipei Medical | 吲哚基或吲哚啉基羥肟酸化合物 |
WO2012172340A2 (en) * | 2011-06-13 | 2012-12-20 | Ith Immune Therapy Holdings | Treating mental disorders |
US9726666B2 (en) | 2011-06-13 | 2017-08-08 | Tla Targeted Immunotherapies Ab | Diagnosing and treating inflammatory diseases |
DK3263564T3 (da) | 2012-02-29 | 2020-09-07 | Chemocentryx Inc | Aza-aryl-1h-pyrazol-1-yl-benzen-sulfonamider som ccr(9)- antagonister |
MX367055B (es) | 2012-06-26 | 2019-08-02 | Del Mar Pharmaceuticals | El uso de una composición que comprende dianhidrogalactitol, diacetildianhidrogalactitol, y dibromodulcitol, y análogos o derivados de cada uno para el tratamiento de malignidades resistentes a inhibidores de tirosina cinasa. |
UY35165A (es) | 2012-12-04 | 2014-06-30 | Takeda Pharmaceutical | Método profiláctico o terapéutico para el síndrome de sjogren |
US11491154B2 (en) | 2013-04-08 | 2022-11-08 | Dennis M. Brown | Therapeutic benefit of suboptimally administered chemical compounds |
WO2015090233A1 (en) | 2013-12-20 | 2015-06-25 | Sunshine Lake Pharma Co., Ltd. | Aromatic heterocyclic compounds and their application in pharmaceuticals |
CN105541693B (zh) | 2014-07-08 | 2018-10-16 | 广东东阳光药业有限公司 | 芳杂环类衍生物及其在药物上的应用 |
IL251136B (en) | 2014-10-06 | 2022-07-01 | Chemocentryx Inc | Combined treatment of c-c receptor inhibitors type 9 (ccr9) and integrin-blocking anti-alha4beta7 antibodies |
BR112018014666B1 (pt) * | 2016-01-20 | 2024-01-02 | Chemocentryx, Inc | Compostos de 2-oxindol, seu uso e composição farmacêutica |
US11492341B2 (en) | 2018-11-16 | 2022-11-08 | Nimbus Artemis, Inc. | ACLY inhibitors and uses thereof |
US10792360B1 (en) | 2019-11-21 | 2020-10-06 | Chemocentryx, Inc. | Compositions and methods for treating inflammatory bowel disease using CCR9 inhibitor and anti-TNF-alpha blocking antibodies |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002072549A1 (en) * | 2001-03-12 | 2002-09-19 | Millennium Pharmaceuticals, Inc. | Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor |
ES2286502T3 (es) * | 2002-11-18 | 2007-12-01 | Chemocentryx, Inc. | Sulfonamidas de arilo. |
-
2008
- 2008-02-04 CN CNA2008800041019A patent/CN101605759A/zh active Pending
- 2008-02-04 AT AT08708667T patent/ATE483685T1/de not_active IP Right Cessation
- 2008-02-04 EA EA200901042A patent/EA200901042A1/ru unknown
- 2008-02-04 EP EP08708667A patent/EP2118060B1/en not_active Not-in-force
- 2008-02-04 JP JP2009547709A patent/JP2010517976A/ja active Pending
- 2008-02-04 AU AU2008212887A patent/AU2008212887A1/en not_active Abandoned
- 2008-02-04 BR BRPI0807836-0A patent/BRPI0807836A2/pt not_active IP Right Cessation
- 2008-02-04 WO PCT/EP2008/051365 patent/WO2008095908A1/en active Application Filing
- 2008-02-04 MX MX2009008425A patent/MX2009008425A/es active IP Right Grant
- 2008-02-04 KR KR1020097016365A patent/KR20090116732A/ko not_active Application Discontinuation
- 2008-02-04 CA CA002676145A patent/CA2676145A1/en not_active Abandoned
- 2008-02-04 DE DE602008002901T patent/DE602008002901D1/de active Active
- 2008-02-04 US US12/525,881 patent/US20100075963A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2008095908A1 (en) | 2008-08-14 |
AU2008212887A1 (en) | 2008-08-14 |
MX2009008425A (es) | 2009-08-17 |
KR20090116732A (ko) | 2009-11-11 |
ATE483685T1 (de) | 2010-10-15 |
CN101605759A (zh) | 2009-12-16 |
EP2118060B1 (en) | 2010-10-06 |
BRPI0807836A2 (pt) | 2014-08-05 |
US20100075963A1 (en) | 2010-03-25 |
EP2118060A1 (en) | 2009-11-18 |
DE602008002901D1 (de) | 2010-11-18 |
JP2010517976A (ja) | 2010-05-27 |
CA2676145A1 (en) | 2008-08-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200901042A1 (ru) | Производные 1-бензенсульфонил-1h-индола в качестве ингибиторов активности ccr9 | |
CY1116455T1 (el) | Υποκατεστημενα 4-αρυλο-1,4-διυδρο-1,6-ναφθυριδιν αμιδια και η χρηση τους | |
DE602005014621D1 (de) | 3-ä4-heterocyclyl-1,2,3-triazol-1-ylü-n-arylbenzamide als inhibitoren der cytokinenproduktion für die behandlung von chronischen entzündlichen erkrankungen | |
EA201170521A1 (ru) | Новые соединения | |
BRPI0909040B8 (pt) | derivados de azetidina e ciclobutano, seus usos, e composição | |
EA200700717A1 (ru) | Сульфонамиды | |
CL2007003341A1 (es) | Compuestos derivados de imidazotriazinas; composicion farmaceutica, util para el tratamiento del cancer, arteroesclerosis y enfermedades cardiovasculares entre otras. | |
DE602007004086D1 (de) | Acrylierte hyaluronsäure | |
MA32811B1 (fr) | Nouveaux composés | |
UY34545A (es) | Novedosas dihidropirimidinoisoquinolinonas y composiciones farmacéuticas de las mismas para el tratamiento de trastornos inflamatorios. | |
EA201290267A1 (ru) | Производные диоксабицикло[3.2.1]октан-2,3,4-триола | |
EA201270049A1 (ru) | Дизамещенные фталазиновые антагонисты пути hedgehog | |
ATE489371T1 (de) | Benzamidglucokinaseaktivatoren | |
BRPI0906618A2 (pt) | Derivados de diazepinorimidona de arilamida substituídos para o tratamento de doenças neu-rodegenerativas causadas por atividade anorma de gsk3-beta | |
CR11423A (es) | NUEVOS INHIBIDORES DE sEH Y SU USO | |
BRPI0814772A2 (pt) | Indazóis substituídos por 5-piridinona | |
CL2007002427A1 (es) | Compuestos derivados heterociclicos, inhibidores de metaloproteinasa de matriz; proceso de preparacion; composicion farmaceutica, util para el tratamiento o profilaxis de enfermedades inflamatorias o desordenes autoinmunes. | |
CU20110215A7 (es) | Piperidinas sustituidas | |
NO20085375L (no) | Nitrerte hetrosykliske forbindelser som endotelin-reseptorantagonist | |
ATE475651T1 (de) | Aryl-substituierte heterozyklen und ihre verwendung | |
NO20092134L (no) | Kombinasjonsprodukt for bruk i behandling av inflammatoriske lidelser | |
EA201190313A1 (ru) | Замещенные пиперидины | |
BR112013009260A2 (pt) | compostos de carboxamida de piridazina substituídos como compostos inibidores de quinase | |
EA200801211A1 (ru) | Производные 9-хлор-15-простагландина, способ их получения и использования в лекарственных препаратах | |
MX2012014983A (es) | Quinolinas como inhibidores pi3k. |